HLB innoVation

024850 · KOSDAQ · ₩024850 · HLB이노베이션

₩14,700▼ ₩160 (1.08%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +40.67%
Market cap
₩508B
Enterprise value
₩491B
P/E
—
P/B
2.1×
Dividend yield
0.0%
ROE
−13.5%
Net margin
−91.2%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−49.5% from the high

₩7,460Today: ₩14,350 – ₩15,400₩29,101

Returns

  • 1W−10.6%
  • 1M−2.9%
  • 3M+84.0%
  • 6M−36.4%
  • YTD+47.4%
  • 1Y+40.7%
Volume today
112,437
0.3× the 20-day average
Traded today
₩1.7B
Listed shares
34,562,271
EPS (12 months)
−₩943
Earnings yield −6.4%

Signals

25Quiet
  • BuzzQuietBuzz 25 of 100 (50 is a normal day for this stock).
  • MomentumFlat2.8% over the last month; the price is below its 20-day average.
  • News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Leveraged ETF flows

Estimated leveraged-ETF rebalance on Oct 26: sell ₩340M at the close (4.5% of 20-day average trading value)

Sep 29Last 9 trading days (% of average trading value)Oct 26

On its 37 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 0.8% of trading value and pointed the same way 4 of 37 times.

  • 2× KODEX KOSDAQ150 Leverage −₩287M
  • -1× KODEX KOSDAQ150 Futures Inverse −₩24M
  • 2× TIGER KOSDAQ150 Leverage −₩21M
  • 2× RISE KOSDAQ150 Futures Leverage −₩6.1M

Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.

Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.

Estimate based on ETF size and daily moves; actual trades may differ.

HLB innoVation stock overview

HLB innoVation (HLB이노베이션, KRX: 024850) is listed on KOSDAQ, in the Electronic components sector. HLB Innovation manufactures semiconductor components, mainly lead frames (including general, pre-mold, and power module types) and contact pins used in chip testing sockets, supplying customers in the global semiconductor assembly and test industry, including automotive, industrial and consumer electronics applications. Its shares closed at ₩14,700 on Oct 27, 2026, down 1.08% on the day, giving it a market value of ₩508B.

Key facts

Market cap
₩508B
Sector
Electronic components
Latest price change
−1.08%
As of
Oct 27, 2026
Main business
HLB Innovation manufactures semiconductor components, mainly lead frames (including general, pre-mold, and power module types) and contact pins used in chip testing sockets, supplying customers in the global semiconductor assembly and test industry, including automotive, industrial and consumer electronics applications.

Quick answers about HLB innoVation

What does HLB innoVation do?
HLB Innovation manufactures semiconductor components, mainly lead frames (including general, pre-mold, and power module types) and contact pins used in chip testing sockets, supplying customers in the global semiconductor assembly and test industry, including automotive, industrial and consumer electronics applications. -based subsidiary Verismo Therapeutics, the company is also developing CAR-T cell therapies, including its KIR-CAR platform aimed at solid tumors and relapsed or refractory blood cancers.
What is the market cap of HLB innoVation?
The market capitalisation of HLB innoVation was ₩508B at the close on Oct 27, 2026.
Who are the largest shareholders of HLB innoVation?
According to the latest official filings, the largest reported holders are HLB (42.32%, as of Oct 2, 2026); MICHAELCHRISTOPHERMILONE (5.61%, as of Nov 7, 2024); BRYANBYONGJINKIM (5.14%, as of Jul 22, 2026).
When is the next earnings report from HLB innoVation?
Korean companies rarely announce results dates in advance. Based on when HLB innoVation filed the same report in past years, its next 3q results is expected between Feb 14, 2026 and Nov 14, 2026.

Company profile

HLB Innovation manufactures semiconductor components, mainly lead frames (including general, pre-mold, and power module types) and contact pins used in chip testing sockets, supplying customers in the global semiconductor assembly and test industry, including automotive, industrial and consumer electronics applications. Through its U.S.-based subsidiary Verismo Therapeutics, the company is also developing CAR-T cell therapies, including its KIR-CAR platform aimed at solid tumors and relapsed or refractory blood cancers.

Written by AI from the company's latest annual report.

Korean name
HLB이노베이션
Themes
—
CEO
진양곤, BRYANBYONGJIN.KIM(각자대표)
Founded
Jun 1978
Listed
Jan 2001
Listed shares
34,562,271
Fiscal year ends
Month 12

Similar companies

Recent news

News · Asia Economy·

HLB Innovation Unveils Preclinical Results of Verismo's Solid Tumor CAR-T

Predicted impact: Low· Actual: −4.2% vs sector, volume 0.3× normal (5 trading days)

Preclinical solid tumor CAR-T data at a conference; early-stage, no revenue size given.

News · Etoday·

HLB Innovation's Verismo Unveils Solid Tumor CAR-T Preclinical Data at SITC, Claims Lower T-Cell Exhaustion and Toxicity

Predicted impact: Low· Actual: −4.2% vs sector, volume 0.3× normal (5 trading days)

Preclinical CAR-T data at a conference; early-stage with no revenue impact.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: HLB innoVation / HLB이노베이션 / 024850 / KRX:024850

Source: KRX statistical information